Funding for this research was provided by:
Full statement provided in manuscript
Received: 12 September 2020
Accepted: 3 February 2021
First Online: 12 March 2021
Ethics approval and consent to participate
: This research was approved by the University of Sydney Human Research Ethics Committee (Project number: 2018/833).
: Not applicable.
: Authors AS, FI, KL, JS, WB, TD, and DH declare they have no conflicts of interest relevant to this work.A/Professor Jo-An Occhipinti (née Atkinson) is both Head of Systems Modelling, Simulation & Data Science at the University of Sydney’s Brain and Mind Centre and Managing Director of Computer Simulation & Advanced Research Technologies (CSART). Professor Ian Hickie was an inaugural Commissioner on Australia’s National Mental Health Commission (2012–2018). He is the Co-Director, Health and Policy at the Brain and Mind Centre (BMC) University of Sydney, Australia. The BMC operates an early-intervention youth services at Camperdown under contract to headspace. Professor Hickie has previously led community-based and pharmaceutical industry-supported (Wyeth, Eli Lily, Servier, Pfizer, AstraZeneca) projects focused on the identification and better management of anxiety and depression. He was a member of the Medical Advisory Panel for Medibank Private until October 2017, a Board Member of Psychosis Australia Trust and a member of Veterans Mental Health Clinical Reference group. He is the Chief Scientific Advisor to, and a 5% equity shareholder in, InnoWell Pty Ltd. InnoWell was formed by the University of Sydney (45% equity) and PwC (Australia; 45% equity) to deliver the $30 M Australian Government-funded Project Synergy (2017–2020; a 3-year program for the transformation of mental health services) and to lead transformation of mental health services internationally through the use of innovative technologies.